Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemia

Clinical and Investigative Medicine

Volumn 30, Issue 5, 2007, Pages

  Falasca, Katia ^a,b   Mancino, Paola ^a   Ucciferri, Claudio ^a   Dalessandro, Margherita ^a,b   Zingariello, Pompea ^a,b   Lattanzio, Franca M ^c   Castellani, Maria L ^a   Martinotti, Stefano ^c   Pizzigallo, Eligio ^a,b   Conti, Pio ^a   Vecchiet, Jacopo ^a,b  

^a UNIVERSITY OF CHIETI   (Italy)

^b Center of Excellence on Aging   (Italy)

^c CCU SS Annunziata Hospital   (Italy)

Author keywords

Cryoglobulinemia; Cytokines; HCV; Hepatitis; S 100b protein

Indexed keywords

CRYOGLOBULIN; CYTOKINE; INTERLEUKIN 18; INTERLEUKIN 6; PROTEIN S100B; VIRUS RNA;

ADULT; ARTHRALGIA; ARTICLE; CHRONIC DISEASE; CORRELATION ANALYSIS; CRYOGLOBULINEMIA; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PURPURA; TH1 CELL; TH2 CELL; WEAKNESS;

ADULT; CRYOGLOBULINEMIA; CYTOKINES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; S100 PROTEINS; TH1 CELLS; TH2 CELLS;

EID: 35948961560     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Gunber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med. 1995;123:615-20.
2. Garini G, Allegri L, Vaglio A, et al. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies. Ann Ital Med Int. 2005;20:71-80.
3. Penta M, Fioriti D, Chinazzi A, et al. Encrusted cystitis in an immunocompromised patient: possible coinfection by Corynebacterium urealyticum and E. coli. Int J Immunopathol Pharmacol 2006;19:241-4.
4. Ausiello CM, Palazzo R, Spensieri F,et al. Soluble CD30 and lymphocyte activation gene-3 (CD223), as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine. Int J Immunopathol Pharmacol 2006;19:97-104
5. Brouet JC, Clauvel JP, Danon F, et al Biologic and clinical significance of cryoglobulins: a report of 86 cases. Ann J Med. 1974;57:775-88.
6. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol. 2002;55:4-13.
7. Pugliese L, Bernardini I, Viola-Magni MP, Albi E. Low levels o serum cholesterol/phospholipids are associated with the antiphospholipid antibodies in monoclonal gammopathy. Int J Immunopathol Pharmacol 2006;19(2):331-8.
8. Castellani ML, Salini V, Frydas S, et al. Interleukin-31: a new cytokine involved in inflammation of the skin. Int J Immunopathol Pharmacol 2006;19:1-4.
9. Choucair N, Laporte V, Levy R, et al. The role of calcium and magnesium ions in uptake of β-amyloid peptides by microglial cells. Int J Immunopathol Pharmacol 2006;19:683-96.
10. Gorevic PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med. 1980;69:287-308.
11. Meltzer M, Franklin EC, Elias K, et al. Cryoglobulinemia. A clinical and laboratory study. II. Cryoglobulin with rheumatoid factor activity. Am J Med. 1966;40:837-56.
12. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;123:615-20.
13. Ferri C, Greco F, Longobardo G, et al. Association between hepatitis C virus and mixed cryoglobulinaemia. Clin Exp Rheumatol. 1991;9:621-4.
14. 2receptor up-regulation induced by guanosin or UTP in rat brain cultured astrocytes. Int J Immunopathol Pharmacol 2006;19:293-308.
15. Lanza A, De Rosa A, Femiano F, et al. Internalization of non-clustered desmoglein 1 without depletion of desmoglein 1 from adhesion complexes in an experimental model of the autoimmune disease pemphigus foliaceus. Int J Immunopathol Pharmacol 2007;20:355-62.
16. Cacoub P, Renou C, Resenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherge en Medicine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 2000;79:47-56.
17. Monti G, Galli M, Invernizzi F, et al. Cryoglobulinemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM. 1995;88:115-26.
18. Drummer HE, Wilson KA, Poubourios P, et al. Identification of the hepatitis C virus E2 glycoprotein binding site on the large extra-cellular loop of CD81. J Virol. 2002;76:11143-7.
19. Lazarova P, Wu Q, Kvalheim G, et al. Growth factor receptors in hematopoietic stem cells: Eph family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood. Int J Immunopathol Pharmacol 2006;19:49-56.
20. Cantaluppi V, Deregibus MC, Biancone L, et al. The expression of CD154 by Kaposi's sarcoma cells mediates the anti-apoptotic and migratory effects of HIV-1-Tat protein. Int J Immunopathol Pharmacol 2006;19:81-96.
21. Lanzilli G, Falchetti R, Cottarelli A, et al. In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes. Int J Immunopathol Pharmacol 2006;19:551-60.
22. Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol. 2005;175:3463-8.
23. Li DH, Kumanogoh A, Cao TM, et al. Woodchuck interleukin-6 gene: structure, characterization and biologic activity. Gene 2004;342:157-64.
24. Vecchiet J, Falasca K, Cacciatore P, et al. Association between plasma Interleukin-18 levels and liver injury in chronic hepatitis C virus infection and nonalcoholic fatty liver. Ann Clin Lab Sci. 2005;35:415-22.
25. Vassilopoulos D. Calabrese LH. Extrahepatic immunological complications of hepatitis C virus infection. AIDS 2005;19:S123-S127.
26. Staibano S, Mascolo M, Tranfa F, et al. Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behaviour? Int J Immunopathol Pharmacol 2006;19:171-80.
27. Torres MJ, Mayorga C, Fernández TD, et al. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. Int J Immunopathol Pharmacol 2006;19:119-30.
28. Hsieh HL, Schafer BW, Weigle B, Heizmann C. S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation end products in human endothelial cells. BBRC. 2004;316:949-59.
29. Fagnart OC, Sindic CJ, Laterre C. Particle counting immunoassay of S-100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem. 1988;34:1387-91.
30. Infante JR, Martinez A, Ochoa J, et al. Cerebrospinal fluid S-100 protein levels in neurological pathologies. J Physiol Biochem. 2003;59:255-61.
31. Makino E, Sakaguchi M, Iwatsuki K, et al. Introduction of an N-terminal peptide of S100C/A11 into human cells induces apoptotic cell death. J Mol Med. 2004;82:612-20.
32. Greco C, D'Agnano I, Vitelli G, et al. c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB. Int J Immunopathol Pharmacol 2006;19:67-80.
33. Ciardelli L, Garofoli F, Avanzini MA, et al. Escherichia coli specific secretory IgA and cytokines in human milk from mothers of different ethnic groups resident in northern Italy. Int J Immunopathol Pharmacol 2007;20:335-40.
34. Wright H, Alex P, Nguyen T, et al. Multiplex cytokine profiling of initial therapeutic response in patients with chronic hepatitis C virus infection. Dig Dis Sci. 2005;50:1793-803.
35. Saadoun D, Boyer O, Trébeden-Nègre H, et al. Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis. J Hepatol. 2004;23:246-53.
36. Falasca K, Ucciferri C, Dalessandro M, et al. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Scie. 2006:36:144-50.
37. Feldmann G, Nischalke HD, Nattermann J, et al. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma. Clin Cancer Res 2006;12(15):4491-8.
38. Ivanova L, Russev V. Chronic liver diseases and parentally transmitted hepatitis viruses. Eur J Inflamm 2007;5:1-6
39. Dalessandro M, Petrarca C, Falasca K, et al. Could S-100b be a marker of the neurologic involvement in HIV-affected patients?. Int J Immunopathol Pharmacol 2006;19(4):939-42.
40. Reddy MA, Li SL, Sahar S, et al. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem 2006;281:13685-93.
41. Vincent AM, Perrone L, Sullivan KA, et al. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 2007;148:548-58.